Literature DB >> 12223243

Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia.

Grazyna Rajkowska1, Jose Javier Miguel-Hidalgo, Zoltan Makkos, Herbert Meltzer, James Overholser, Craig Stockmeier.   

Abstract

Neuroimaging studies have implicated the prefronto-striatal loop as a substrate for the cognitive deficits in schizophrenia (SCHZ). Postmortem morphometric studies reveal that layers III and V of the dorsolateral prefrontal cortex (dlPFC), which gave rise to glutamatergic projections to neostriatum, demonstrate the most structural pathology in this region of the SCHZ. These neuronal alterations in SCHZ are not accompanied by marked glial changes as revealed by Nissl staining. We examined the glial-type specific pathology in SCHZ by analyzing the glial fibrillary acidic protein- (GFAP) immunoreactive astroglia in contrast to the Nissl-stained general pool of glial cells in dlPFC (area 9) from 9 subjects with SCHZ and 15 psychiatrically normal control subjects. In layer V of the dlPFC in SCHZ, there was a significant 32% reduction in the GFAP-area fraction, 81% increase in the density of the GFAP-positive cell bodies and a 14% decrease in the width of the cortical layer V, as compared to the control subjects. None of these parameters were affected in layers III and IV in the SCHZ. Therefore, only subtle, type- and layer-specific glial pathology is present in the dlPFC in SCHZ. Astroglial pathology in dlPFC may reflect disturbances of the neuron-glia interactions in layer V and may be related to the dysfunctional prefronto-striatal circuits, dopaminergic alterations and cognitive pathology in SCHZ.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12223243     DOI: 10.1016/s0920-9964(02)00339-0

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  57 in total

1.  Astrocyte decrease in the subgenual cingulate and callosal genu in schizophrenia.

Authors:  Matthew Roy Williams; Thomas Hampton; Ronald K B Pearce; Steven Richard Hirsch; Olaf Ansorge; Maria Thom; Michael Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-06-04       Impact factor: 5.270

2.  Astrocytic cytoskeletal atrophy in the medial prefrontal cortex of a triple transgenic mouse model of Alzheimer's disease.

Authors:  Magdalena Kulijewicz-Nawrot; Alexei Verkhratsky; Alexander Chvátal; Eva Syková; José J Rodríguez
Journal:  J Anat       Date:  2012-06-27       Impact factor: 2.610

Review 3.  Translational potential of astrocytes in brain disorders.

Authors:  Alexei Verkhratsky; Luca Steardo; Vladimir Parpura; Vedrana Montana
Journal:  Prog Neurobiol       Date:  2015-09-16       Impact factor: 11.685

4.  Evaluation of Myo-Inositol as a Potential Biomarker for Depression in Schizophrenia.

Authors:  Joshua Chiappelli; Laura M Rowland; S Andrea Wijtenburg; Florian Muellerklein; Malle Tagamets; Robert P McMahon; Frank Gaston; Peter Kochunov; L Elliot Hong
Journal:  Neuropsychopharmacology       Date:  2015-02-27       Impact factor: 7.853

Review 5.  Glial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity?

Authors:  Mark J Niciu; Ioline D Henter; Gerard Sanacora; Carlos A Zarate
Journal:  World J Biol Psychiatry       Date:  2013-09-12       Impact factor: 4.132

Review 6.  Searching for neuropathology: gliosis in schizophrenia.

Authors:  Tatiana P Schnieder; Andrew J Dwork
Journal:  Biol Psychiatry       Date:  2010-10-30       Impact factor: 13.382

7.  Expression of mutant human DISC1 in mice supports abnormalities in differentiation of oligodendrocytes.

Authors:  Pavel Katsel; Weilun Tan; Bagrat Abazyan; Kenneth L Davis; Christopher Ross; Mikhail V Pletnikov; Vahram Haroutunian
Journal:  Schizophr Res       Date:  2011-05-24       Impact factor: 4.939

8.  Neuropathological changes in the nucleus basalis in schizophrenia.

Authors:  M R Williams; R Marsh; C D Macdonald; J Jain; R K B Pearce; S R Hirsch; O Ansorge; S M Gentleman; M Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-12-11       Impact factor: 5.270

9.  Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia.

Authors:  Amy E Steffek; Robert E McCullumsmith; Vahram Haroutunian; James H Meador-Woodruff
Journal:  Schizophr Res       Date:  2008-06-17       Impact factor: 4.939

10.  Evidence for morphological alterations in prefrontal white matter glia in schizophrenia and bipolar disorder.

Authors:  Christa Hercher; Vikramjit Chopra; Clare L Beasley
Journal:  J Psychiatry Neurosci       Date:  2014-11       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.